These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4119813)

  • 41. Candicidin: physiologic effect on prostate.
    Sporer A; Cohen S; Kamat MH; Seebode JJ
    Urology; 1975 Sep; 6(3):298-304. PubMed ID: 51533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Giant bladder due to prostatic hyperplasia and consecutive obstruction].
    Ropers D; Samuel U
    Dtsch Med Wochenschr; 2007 Mar; 132(13):671-2. PubMed ID: 17377881
    [No Abstract]   [Full Text] [Related]  

  • 43. [Dissection of prostate coalesce in treatment of benign prostate hypertrophy with relatively small volume].
    Qiu MX; Wang D; Wu HM; Xiong GB; Chen ZX
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1852-3. PubMed ID: 17922999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical management of lower urinary tract symptoms with combined medical therapy.
    Roehrborn CG
    BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605
    [No Abstract]   [Full Text] [Related]  

  • 45. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian survey.
    Kaplan SA
    J Urol; 2005 Jun; 173(6):2058. PubMed ID: 15879832
    [No Abstract]   [Full Text] [Related]  

  • 47. [Early results of the use of levorin in prostatic adenoma].
    Kliucharev BV; Berman NA; Ivanov NM; Margolin AM; Mikhaĭlets GA
    Vopr Onkol; 1972; 18(5):36-41. PubMed ID: 4114572
    [No Abstract]   [Full Text] [Related]  

  • 48. Response of the benign hypertrophied prostate to treatment with an LHRH analogue.
    Keane PF; Timoney AG; Kiely E; Williams G; Stamp G
    Br J Urol; 1988 Aug; 62(2):163-5. PubMed ID: 2457404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Gerber GS
    Urology; 1996 Nov; 48(5):668-75. PubMed ID: 8911507
    [No Abstract]   [Full Text] [Related]  

  • 50. Symptoms and symptom scores in BPH.
    Reynard J; Abrams P
    Scand J Urol Nephrol Suppl; 1994; 157():137-45. PubMed ID: 7524140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Candicidin in treatment of benign prostatic hypertrophy.
    Madsen PO; Dørflinger T; Frimodt-Møller PC; Jensen KM
    J Urol; 1984 Dec; 132(6):1235-8. PubMed ID: 6209428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Candicidin treatment of prostatism: a prospective double-blind placebo-controlled study.
    Jensen KM; Madsen PO
    Urol Res; 1983; 11(1):7-10. PubMed ID: 6190290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The treatment of benign enlargement of the prostate with nor progesterone caproate (primostat).
    Subbiah N; Mortensen J
    Aust N Z J Surg; 1973 Feb; 42(3):304-7. PubMed ID: 4129814
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter: Candicidin for benign prostatic hypertrophy.
    Tessler AN
    Urology; 1974 Oct; 4(4):494-5. PubMed ID: 4138275
    [No Abstract]   [Full Text] [Related]  

  • 55. Phenoxybenzamine for benign prostatic obstruction. Review of 200 cases.
    Caine M; Perlberg S; Shapiro A
    Urology; 1981 Jun; 17(6):542-6. PubMed ID: 6166111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bladder outlet obstruction caused by vaginal fibromyoma: the female prostate.
    Freed SZ; Haleem SA; Wiener I; Feldman J
    J Urol; 1975 Jan; 113(1):30-1. PubMed ID: 46288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of candicidin in benign prostatic hypertrophy.
    Orkin LA
    Urology; 1974 Jul; 4(1):80-4. PubMed ID: 21322990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of polyene macrolides on the prostate gland and canine prostatic hyperplasia.
    Gordon HW; Schaffner CP
    Proc Natl Acad Sci U S A; 1968 Aug; 60(4):1201-8. PubMed ID: 4175273
    [No Abstract]   [Full Text] [Related]  

  • 59. Antimycotics in hypertrophy of the prostate.
    Aalkjaer V
    Urol Int; 1970; 25(2):196-200. PubMed ID: 4192914
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy.
    Aubrey DA; Khosla T
    Br J Surg; 1971 Sep; 58(9):648-52. PubMed ID: 4105896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.